the aid library

LIST OPTIONS

Filter

3448

Sort by:

Direction:

Download (456)

View PDF (2273)

Cholera Outbreak: assessing the outbreak response and improving preparedness

Global Task Force on Cholera Control World Health Organization (WHO) (2010)

Download (74)

View PDF (110)

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for key populations

C. Beyrer; A. Kamarulzaman; E. Aaraj; et al. World Health Organization WHO (2016) CC

2016 Update Key population

Download (209)

View PDF (521)

Roadmap towards ending TB in children and adolescents
recommended

World Health Organization WHO (2018) C_WHO

2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and... more

Download (110)

View PDF (159)

Social determinants approaches to public health: from concept to practice

Erik Blas, Johannes Sommerfeld and Anand Sivasankara Kurup World Health Organization WHO (2011) C_WHO

Download (166)

View PDF (238)

The Power of Cities: Tackling Noncommunicable Diseases and Road Traffic Injuries

World Health Organization WHO (2019) C_WHO

The report is geared towards mayors, local government officials and city policy planners.It highlights key areas where city leaders can tackle the drivers of NCDs, including tobacco use, air pollution, poor diets and lack of exercise, and improve road safety. From anti-tobacco actions in Beijing a... more

Download (684)

View PDF (948)

Classification and minimum standards for Foreign Medical Teams in sudden onset disasters

World Health Organization (WHO) ; Global Health Cluster (2013) C_WHO

The document introduces a simple classification, minimums standards and a registration form for Foreign Medical Teams (FMTs) that may provide surgical and trauma care arriving within the aftermath of a sudden onset disaster. These can serve as tools to improve the coordination of the foreign medical... more

Download (264)

View PDF (377)

Reaching the every newborn national 2020 milestones: country progress, plans and moving forward

World Health Organization (WHO), UNICEF (2017) C_WHO

To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor... more

Download (407)

View PDF (667)

Waterborne Outbreaks of Hepatitis E: recognition, investigation and control

World Health Organization (WHO) (2014) C_WHO

Technical report
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology... more

Download (365)

View PDF (715)

Population mobility and malaria

World Health Organization ( WHO), Regional Oﬃce for South-East-Asia (2017) C_WHO

Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul... more

Download (260)

View PDF (317)

Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended

World Health Organization WHO (2020) C1

To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo... more

Download (69)

View PDF (108)

Water, sanitation and hygiene in healthcare facilities: practical steps to achieve universal access to quality care

World Health Organization WHO, Unicef (2019) C_WHO

Purpose of this document: to present eight practical steps that Member States can take at the national and sub-national level to improve WASH in health care facilities

Download (115)

View PDF (131)

Turning Plans into Action for antimicrobial Resistance (AMR) Working Paper 2.0: Implementation and coordination

World Health Organization WHO (2019) C_WHO

This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a... more

Download (106)

View PDF (109)

Western Pacific Regional action plan for the prevention and control of noncommunicable diseases (‎2014-2020)‎

World Health Organization WHO (2014) CC

The Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014–2020) was developed in response to a resolution adopted at the sixty-second session of the WHO Regional Committee for the Western Pacific. The regional plan is fully harmonized with... more

Download (112)

View PDF (123)

Planning and implementing palliative care services: a guide for programme managers

World Health Organization WHO (2016) C_WHO

Download (208)

View PDF (264)

Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer

World Health Organization WHO (2020) C_WHO

This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the... more

Download (339)

View PDF (308)

Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the national level

World Health Organization WHO (2021) C_WHO

14 Dec 2021

Download (60)

View PDF (105)

Report of Access to COVID-19 Tools Accelerator Facilitation Council Working Group on Diagnostics and Therapeutics

World Health Organization WHO (2022) C_WHO

This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k... more

Download (102)

View PDF (112)

Keeping the vector out: housing improvements for vector control and sustainable development

Kraef, C.; Röbbel, N. World Health Organization WHO (2017) C_WHO

Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (118)

View PDF (93)

Pediatric Oncology nursing practice in Latin America and the Carribbean

World Health Organization WHO (2023) C_WHO

This technical report has been developed within the framework of the WHO Global Initiative for Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide, giving them the best chances of survival, living a full life and, above all, enjoying quality of ... more

Roadmap towards ending TB in children and adolescents recommended

Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease recommended

Roadmap towards ending TB in children and adolescents
recommended

Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended